Trade Mark Journal No.2026/042 16 October 2026
WO0000001939648 (5)
Office of origin: United States of America
Date of International Registration:26 August 2026
Date of designation in the UK:
26 August 2026

International priority date claimed: 26 August 2026
(United States of America)
(50073594)
- Class 5
- Pharmaceutical preparations for the treatment of anaphylaxis; pharmaceutical preparations for the treatment of of allergic reactions, namely, emergency treatment of type i allergic reactions; pharmaceutical preparations for the treatment of low blood pressure, intraocular pressure and bronchoconstriction.
Hikma Pharmaceuticals USA Inc.
Representative: Deborah L. Corpus Chrisman Gallo Tochtrop LLC, 629 Euclid Ave.,, Suite 1101, Cleveland OH 44114, UNITED STATES OF AMERICA